Azizi M - Search Results

1

Progress in primary aldosteronism. Mineralocorticoid antagonist treatment for aldosterone-producing adenoma.

Amar L, Lorthioir A, Azizi M, Plouin PF. Amar L, et al. Among authors: azizi m. Eur J Endocrinol. 2015 Mar;172(3):R125-9. doi: 10.1530/EJE-14-0585. Epub 2014 Oct 14. Eur J Endocrinol. 2015. PMID: 25315875 Review.

2

Split renal function outcome after renal angioplasty in patients with unilateral renal artery stenosis.

Batide-Alanore A, Azizi M, Froissart M, Raynaud A, Plouin PF. Batide-Alanore A, et al. Among authors: azizi m. J Am Soc Nephrol. 2001 Jun;12(6):1235-1241. doi: 10.1681/ASN.V1261235. J Am Soc Nephrol. 2001. PMID: 11373347

3

Proteinuria in renal artery occlusion is related to active renin concentration and contralateral kidney size.

Rossignol P, Chatellier G, Azizi M, Plouin PF. Rossignol P, et al. Among authors: azizi m. J Hypertens. 2002 Jan;20(1):139-44. doi: 10.1097/00004872-200201000-00020. J Hypertens. 2002. PMID: 11791037

4

Images in cardiovascular medicine. Pheochromocytoma of the urinary bladder.

Lamarre-Cliche M, Hernigou A, Boutouyrie P, Plouin PF, Azizi M. Lamarre-Cliche M, et al. Among authors: azizi m. Circulation. 2002 Oct 15;106(16):2143-4. doi: 10.1161/01.cir.0000037120.95689.d8. Circulation. 2002. PMID: 12379587 No abstract available.

5

Aldosterone synthase inhibition with LCI699: a proof-of-concept study in patients with primary aldosteronism.

Amar L, Azizi M, Menard J, Peyrard S, Watson C, Plouin PF. Amar L, et al. Among authors: azizi m. Hypertension. 2010 Nov;56(5):831-8. doi: 10.1161/HYPERTENSIONAHA.110.157271. Epub 2010 Sep 13. Hypertension. 2010. PMID: 20837883 Clinical Trial.

6

[Renal-nerve ablation in patients with resistant hypertension: caution is still needed].

Steichen O, Sapoval M, Frank M, Bobrie G, Plouin PF, Azizi M. Steichen O, et al. Among authors: azizi m. Presse Med. 2012 Apr;41(4):349-57. doi: 10.1016/j.lpm.2011.05.009. Epub 2011 Jul 2. Presse Med. 2012. PMID: 21724360 Review. French.

7

Endovascular renal artery denervation: why, when, and how?

Sapoval M, Azizi M, Bobrie G, Cholley B, Pagny JY, Plouin PF. Sapoval M, et al. Among authors: azizi m. Cardiovasc Intervent Radiol. 2012 Jun;35(3):463-71. doi: 10.1007/s00270-011-0306-8. Cardiovasc Intervent Radiol. 2012. PMID: 22314774 Review.

8

Sequential nephron blockade versus sequential renin-angiotensin system blockade in resistant hypertension: a prospective, randomized, open blinded endpoint study.

Bobrie G, Frank M, Azizi M, Peyrard S, Boutouyrie P, Chatellier G, Laurent S, Menard J, Plouin PF. Bobrie G, et al. Among authors: azizi m. J Hypertens. 2012 Aug;30(8):1656-64. doi: 10.1097/HJH.0b013e3283551e98. J Hypertens. 2012. PMID: 22728905 Clinical Trial.

9

Aldosterone synthase inhibition in humans.

Azizi M, Amar L, Menard J. Azizi M, et al. Nephrol Dial Transplant. 2013 Jan;28(1):36-43. doi: 10.1093/ndt/gfs388. Epub 2012 Oct 8. Nephrol Dial Transplant. 2013. PMID: 23045428 Review.

10

Eligibility for renal denervation in patients with resistant hypertension: when enthusiasm meets reality in real-life patients.

Savard S, Frank M, Bobrie G, Plouin PF, Sapoval M, Azizi M. Savard S, et al. Among authors: azizi m. J Am Coll Cardiol. 2012 Dec 11;60(23):2422-4. doi: 10.1016/j.jacc.2012.08.1002. Epub 2012 Nov 7. J Am Coll Cardiol. 2012. PMID: 23141491 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

974 results

Search Page

Filters